Capital International Investors Insulet Corp Transaction History

Capital International Investors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$212.22 - $313.46 $636 - $940	-3 Reduced -0.0%	77,900 $22.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.6 - $281.45 $673 - $844	3 Added 0.0%	77,903 $17.9 Million
Q1 2021 May 14, 2021	SELL	$235.95 - $293.05 $52.4 Million - $65 Million	-221,949 Reduced 74.02%	77,900 $20.3 Million
Q4 2020 Feb 12, 2021	SELL	$215.97 - $265.89 $7,342 - $9,040	-34 Reduced 0.01%	299,849 $76.7 Million
Q3 2020 Nov 13, 2020	BUY	$192.55 - $236.59 $293,061 - $360,089	1,522 Added 0.51%	299,883 $70.9 Million
Q2 2020 Aug 14, 2020	BUY	$159.17 - $224.73 $5.3 Million - $7.48 Million	33,292 Added 12.56%	298,361 $58 Million
Q1 2020 May 15, 2020	BUY	$130.01 - $216.44 $245,068 - $407,989	1,885 Added 0.72%	265,069 $43.9 Million
Q4 2019 Feb 18, 2020	BUY	$144.81 - $186.0 $19.8 Million - $25.4 Million	136,484 Added 107.72%	263,184 $45.1 Million
Q2 2019 Aug 14, 2019	SELL	$82.13 - $120.73 $3.8 Million - $5.59 Million	-46,300 Reduced 26.76%	126,700 $15.1 Million
Q3 2018 Nov 14, 2018	BUY	$81.43 - $108.13 $14.1 Million - $18.7 Million	173,000 New	173,000 $18.3 Million

754

63.4M

467K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.